Mosaic ImmunoEngineering Inc.
CPMV · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | – | – | – |
| - Cash | $32 | $54 | $86 | $115 |
| + Debt | $1,447 | $1,429 | $1,411 | $1,393 |
| Enterprise Value | – | – | – | – |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$144 | -$149 | -$161 | -$129 |
| % Margin | – | – | – | – |
| Net Income | -$165 | -$172 | -$181 | -$153 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.023 | -0.024 | -0.025 | -0.021 |
| % Growth | 4.2% | 5.2% | -19% | – |
| Operating Cash Flow | $146 | -$32 | -$29 | -$21 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $146 | -$32 | -$29 | -$21 |